Xomics is a pre-IND stage biopharma that strives to translate our rapidly expanding knowledge of transporter proteins into novel, first-in-class medicines to address unmet medical needs in treating cancer, metabolic disorders and genetic diseases. Xomics has operations in San Francisco Bay Area and Shanghai.
Investors 1
| Date | Name | Website |
| 10.10.2020 | MBC BioLab... | mbcbiolabs... |